CLASS III Drug recall · Reported 21 Nov 2012 · FDA Enforcement Report

Tobramycin Ophthalmic Oint., 3%, (Generic for: Tobrex) recalled

Stat Rx U is recalling Tobramycin Ophthalmic Oint., 3%, (Generic for: Tobrex), distributed in Florida, Pennsylvania, Virginia. The recall was initiated on 18 Jun 2012 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot 06JN1265 Exp 3/14 and 06JN1266 Exp 4/14
Quantity recalled22 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-050-2013
FDA event ID
62940
Recalling firm
Stat Rx U, Gainesville, GA
Classification
Class III
Status
Terminated
Recall initiated
18 Jun 2012
FDA classified
9 Nov 2012
Reported
21 Nov 2012
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Sterility
Drug class
Eye Drops

Timeline

18 Jun 2012Recall initiated by company
9 Nov 2012Classified by FDA+144 days
21 Nov 2012Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Label Mix-up: The affected units were labeled incorrectly describing the product as "ointment" instead of "solution."

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Tobramycin Ophthalmic Oint., 0.3%, 5ml bottle, (Generic for: Tobrex), Rx only, Sterile, Mfg By Akorn, Inc., Lake Forest, IL 60045, NDC 16590-224-05,

Where it was distributed

FL, PA, and VA.

FloridaPennsylvaniaVirginia

Questions about this recall

Is Tobramycin Ophthalmic Oint., 3%, (Generic for: Tobrex) recalled?

Yes. Stat Rx U recalled Tobramycin Ophthalmic Oint., 3%, (Generic for: Tobrex) on 18 Jun 2012. The recall is Class III and its status is Terminated. Recall number D-050-2013.

Why was it recalled?

Labeling: Label Mix-up: The affected units were labeled incorrectly describing the product as "ointment" instead of "solution."

Which lots are affected?

Lot 06JN1265 Exp 3/14 and 06JN1266 Exp 4/14

Where was it sold?

FL, PA, and VA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Stat Rx U

All 4